Concepedia

Prognostic Value of Serologic and Histologic Markers on Clinical Relapse in Ulcerative Colitis Patients With Mucosal Healing

Talat Bessissow, Bart Lemmens, Marc Ferrante, Raf Bisschops, Kristel Van Steen, Karel Geboes, Gert Van Assche, Séverine Vermeire, Paul Rutgeerts, Gert De Hertogh

The American Journal of Gastroenterology · 2012 · 286 citations · 21 references

DOI

Abstract

We demonstrated that the presence of basal plasmacytosis predicts UC clinical relapse in patients with complete mucosal healing. We recommend closer follow-up and optimization of medical therapy in patients with basal plasmacytosis.

References

21

Maintenance infliximab for Crohn's disease: the ACCENT I randomised trial

Stephen B. Hanauer, Brian G. Feagan, Gary R. Lichtenstein et al. · The Lancet · 2002 · 4.1K citations

, , +5

Infliximab for Induction and Maintenance Therapy for Ulcerative Colitis

Paul Rutgeerts, William J. Sandborn, Brian G. Feagan et al. · New England Journal of Medicine · 2005 · 3.8K citations · Full text

Coated Oral 5-Aminosalicylic Acid Therapy for Mildly to Moderately Active Ulcerative Colitis

Kenneth W. Schroeder, William J. Tremaine, Duane M. Ilstrup · New England Journal of Medicine · 1987 · 3K citations

Severity of inflammation is a risk factor for colorectal neoplasia in ulcerative colitis

Matthew D. Rutter, Brian P. Saunders, Kay H. Wilkinson et al. · Gastroenterology · 2004 · 1.2K citations

, , +7

Mucosal Healing in Inflammatory Bowel Disease: Results From a Norwegian Population-Based Cohort

Kathrine Frey Frøslie, Jørgen Jahnsen, Bjørn Moum et al. · Gastroenterology · 2007 · 1.1K citations

, , +8